Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Elevance Health, Inc. Director's Dealing 2019

Nov 14, 2019

29933_dirs_2019-11-14_4cba3ae1-7f71-4919-bca9-b13f8bc21475.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anthem, Inc. (ANTM)
CIK: 0001156039
Period of Report: 2019-11-12

Reporting Person: Penczek Ronald W (SVP, Chief Accounting Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-11-12 Common Stock M 357 $166.97 Acquired 2295 Direct
2019-11-12 Common Stock S 357 $282.00 Disposed 1938 Direct
2019-11-13 Common Stock M 816 $232.04 Acquired 2754 Direct
2019-11-13 Common Stock S 816 $287.00 Disposed 1938 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-11-12 Employee Stock Option (Right to Buy) $166.97 M 357 Disposed 2027-03-01 Common Stock (357) Direct
2019-11-13 Employee Stock Option (Right to Buy) $232.04 M 816 Disposed 2028-03-01 Common Stock (816) Direct

Footnotes

F1: The option represents a right to purchase a total of 2,141 shares, and is exercisable in six semi-annual installments, with one installment of 356 shares and five installments of 357 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date.

F2: The option represents a right to purchase a total of 1,634 shares, and is exercisable in six semi-annual installments, with four installments of 272 shares each and two installments of 273 shares each, beginning on September 1, 2018, which is the six-month anniversary of the option grant date.